Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cholinergic receptor muscarinic type 3 (M3) is a G protein-coupled receptor that mediates smooth muscle contraction, glandular secretion, and insulin release. It is widely distributed throughout the body and plays a crucial role in parasympathetic nervous system function. As a therapeutic target, it is primarily addressed in airway diseases like COPD and asthma with drugs like tiotropium.
Antagonism of M3 receptors leading to smooth muscle relaxation and reduced secretions.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cholinergic Receptor Muscarinic Type 3 (M3).